Skip to content

DR. M. HULSELMANS

Active
Private limited companyfounded 2012active for 14 yearsKloostersteeg 10, 3680 Maaseik, BelgiumKBO/BCE: BE 0847.586.592
Summary

DR. M. HULSELMANS has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.4m and a net result of €518,469. Equity is growing by about 20% per year across the filed financial years. Its solvency ranks better than 95% of 20,659 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
DR. M. HULSELMANSActiveChecked score 97/100
Risk analysis ReportCompare

Overview

Activity
Specialist medical practice
NACE 86220
3rd largest company by equity in Maaseik, Health and social work sector1 site
Size
≈ €1.1mturnover 2025, estimated
Equity
€2.4m
Profit
€518,469
Turnover estimated from the gross margin
Financial health
97 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
Holdings
2
2025 accounts 23 days early1 of 2 deeds summarised
Why 97lowers riskSector: Human health activities (NACE 86)Figures for financial year 2025 (filed 08-07-2026)Liquidity: current ratio 37.79, cash €536,979Size: total assets €2.5mShow the evidence

Checked score

Score 2025
97 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 77% of its sector peers (NACE 86, small)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 100=
equity 97.4% of total assets
Liquidity 77+5
short-term debt 2.6% · cash 21.5%
Profitability 95-3
return on assets 20.7%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (1,075 companies, NACE 86, small)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026highest value 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit of up to €230,000 on 30-day terms is acceptable
Liquidity ample (current ratio 37.79, compared with 15.49 in 2024, above the usual 1.5; short-term debt: 2.6% and cash: 21.5% of total assets), and 2.6% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, small): better than 77% on solvency, 70% on liquidity, 92% on profitability and 68% on growth.

The bankruptcy probability was computed on 30-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Figures for financial year 2025 (filed 08-07-2026)
NBB · annual accounts
lowers risk · Liquidity: current ratio 37.79, cash €536,979
NBB · annual accounts
lowers risk · Size: total assets €2.5m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 08-07-2026, 23 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
23 days early
2024
27 days early
2023
27 days late
2022
31 days late
2021
2 days early
2020
26 days early
2019
31 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 2 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
31-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Liquidity more than doubledcurrent ratio 37.79
  3. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Positive: Among the best 5% on solvencysector median 63.0% · 20,659 companies 97.4% View
  • Positive: 8 profitable years in a rowprofit 2025: €518,469 8 years View
  • One director decidessole director in office 1 View

By topic

Financials

Financial year
2025
Total assets
€2.5m
Profit
€518,469
Solvency
97.4%
Total assets▲ 9.3%
Net result
20182025
Go to Financials

Timeline

Events
20
Since
2013
Next accounts
by 31-07-2027
  1. 31-12-2024Highest result from 2018 to 2025
  2. 31-12-2024Equity above €2m
  3. 27-08-2024Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
16-07-2012
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about DR. M. HULSELMANS

What is the company number of DR. M. HULSELMANS?
0847.586.592. In Belgium the VAT number is the company number with BE in front: BE 0847.586.592.
Where is DR. M. HULSELMANS based?
The registered office is at Kloostersteeg 10, 3680 Maaseik.Company details
What does DR. M. HULSELMANS do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. M. HULSELMANS?
Private limited company (BV).
When was DR. M. HULSELMANS founded?
On 16-07-2012.
Is DR. M. HULSELMANS still active?
Yes, DR. M. HULSELMANS is an active enterprise in the KBO register.
What is the turnover of DR. M. HULSELMANS?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is DR. M. HULSELMANS profitable?
In financial year 2025, DR. M. HULSELMANS made a profit of €518,469.
Where can I find the annual accounts of DR. M. HULSELMANS?
DR. M. HULSELMANS filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. M. HULSELMANS due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to DR. M. HULSELMANS

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure